CLIMB BIO, INC.
Profile
Company Names
CLIMB BIO, INC.
ELIEM THERAPEUTICS, INC.
Addresses
20 WILLIAM STREET, SUITE 145, WELLESLEY HILLS, MA 02481
PMB #117, 2801 CENTERVILLE ROAD 1ST FL, WILMINGTON, DE 19808
23515 NE NOVELTY HILL RD SUITE B221 #125, REDMOND, WA 98053
23515 NE NOVELTY HILL RD., SUITE B221 #1, REDMOND, WA 98077
200 BERKELEY STREET, 18TH FLOOR, BOSTON, MA 02116
C/O RA CAPITAL MANAGEMENT, 20 PARK PLAZA, BOSTON, MA 02110
Phone Numbers
1-866-857-2596
877-354-3689
14252762300
6502240857
617-778-2500
Entity Type:
CORPORATION
Industry:
BIOTECHNOLOGY, PHARMACEUTICALS
Year Incorporated:
2018
State Incorporated:
DELAWARE
Total Amount Raised:
$321,378,755.00
Number of Funding Rounds:
6
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
6
2026-04-29
$110,076,289.00
$110,076,289.00
$0.00
Equity
5
2024-06-27
$119,999,986.00
$119,999,986.00
$0.00
Equity
4
2021-05-21
$59,999,987.00
$59,999,987.00
$0.00
Equity
3
2020-10-16
$4,999,995.00
$49,999,985.00
$44,999,990.00
Equity
2
2019-10-10
$9,999,997.00
$9,999,997.00
$0.00
Equity
1
2019-02-04
$16,302,501.00
$16,302,501.00
$0.00
Equity
People
First Name
Middle Name
Last Name
Titles
Related Companies
ROBERT
AZELBY
EXECUTIVE OFFICER, DIRECTOR
AOIFE
BRENNAN
EXECUTIVE OFFICER, DIRECTOR
JUDITH
DUNN
DIRECTOR
DAVID-ALEXANDRE
GROS
DIRECTOR
ERIN
LAVELLE
EXECUTIVE OFFICER
ANDREW
LEVIN
DIRECTOR, EXECUTIVE OFFICER
IMMUNETICS, INC.
| ARVINAS HOLDING COMPANY, LLC
| SYNTHORX, INC.
| CLEANBREAK, INC.
| CLEAR CREEK BIO, INC.
| IMBRIA PHARMACEUTICALS, INC.
| ELIEM THERAPEUTICS, INC.
| ATHENEN THERAPEUTICS, INC.
| ARCUATE THERAPEUTICS, INC.
| AEROVATE THERAPEUTICS, INC.
| SANTI THERAPEUTICS, INC.
| CYTEK BIOSCIENCES, INC.
| METAGENOMI TECHNOLOGIES, LLC
| LUSARIS THERAPEUTICS, INC.
| SUPERLUMINAL MEDICINES, INC.
| NAVIGATOR MEDICINES, INC.
| AKTIS ONCOLOGY, INC.
| PAHR THERAPEUTICS, INC.
| LONESTAR MEDICINES, INC.
| SOLSTICE ONCOLOGY, INC.
| SLATE MEDICINES, INC.
| CLIMB BIO, INC.
LIAM
RATCLIFFE
DIRECTOR
ADAM
ROSENBERG
DIRECTOR
STEPHEN
THOMAS
DIRECTOR
JULIO
VEGA
EXECUTIVE OFFICER
DOUGLAS
WILLIAMS
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2026-04-29
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2024-06-27
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2024-06-27
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2021-05-21
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#

